Gastrointestinal conditions Flashcards

1
Q

List six conditions of the GI tract.

A
constipation
irritable bowel syndrome (IBS)
haemorrhoids
cancer
anal fissures and fistula
inflammatory bowel disease (IBD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the prevalence of constipation in the UK?

A

12-12.8 per 1000
worldwide prevalence estimated 14%
2-3 times higher in women than in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the prevalence of IBS?

A

10-20% of the general population
people aged 20-30 years most often affected
twice as common in women as in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prevalence of haemorrhoids?

A

13-36% of the general population

peak prevalence occurs between the ages of 45-65 years in men and women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prevalence of colorectal cancer?

A

fourth most common cancer in the UK
>41,000 new cases diagnosed each year
risk factors: increasing age, genetics and family history (familial adenomatous polyposis, Lynch syndrome), IBD, dietary and lifestyle factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the prevalence of anal fissures (AF)?

A

around 1 in 350 people

common in people aged 15-40 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the prevalence of IBD (ulcerative colitis (UC) and Crohn’s disease (CD)) in the UK?

A

UC - 146,000
CD - 115,000
UC - peak incidence 15-25 years, 2nd peak 55-65 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is irritable bowel syndrome (IBS)?

A

a chronic, relapsing and often life‑long disorder
the exact cause is unknown but it is likely to involve a mix of genetic and environmental factors
symptoms can overlap with other GI disorders (e.g. non‑ulcer dyspepsia, coeliac disease)
people with IBS present to primary care with a wide range of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List some of the possible biological mechanisms that lead to IBS.

A

visceral hypersensitivity
abnormal gastrointestinal immune function
changes in colonic microbiota
abnormal autonomic activity
abnormal central pain processing of afferent gut signals (altered ‘brain-gut interactions’)
abnormal gastrointestinal motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List some of the possible causes or risk factors for IBS.

A

genetics - twin studies and family studies confirm familial aggregation
enteric infection (e.g. following gastroenteritis)
GI inflammation (e.g. secondary to IBD)
diet (e.g. alcohol, caffeine, spicy and fatty foods) - up to 90% of people report that food triggers symptoms
certain drugs (e.g. antibiotics)
psychosocial factors (e.g. stress, anxiety) - influence the physiological functioning of the GI tract via the brain-gut axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List five signs of IBS.

A
bloating (more common in women)
change in stool frequency
altered stool form
rectal mucus
altered stool passage (straining, urgency, or incomplete evacuation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List six symptoms of IBS.

A
abdominal pain
symptoms worse after eating
lethargy
nausea
headache
back pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What factors are required for a diagnosis of IBS?

A

at least two of the six symptoms for at least 6 months according to:
Abdominal pain and discomfort
Bloating
Change in bowel habit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What further consideration is given to confirm a diagnosis of IBS?

A

if abdominal pain or discomfort is relieved by defecation or associated with altered bowel frequency or stool form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Rome IV criteria for IBS classification?

A

four sub-types
classified by the predominant stool type
it is recognised they exist on a spectrum depending on the person’s quantity, intensity, and severity of different symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the four sub-types of the Rome IV criteria for IBS classification?

A
diarrhoea predominant (IBS-D) (most common)
constipation predominant (IBS-C).
mixed, fluctuating between diarrhoea and constipation (IBS-M)
unclassified (IBS-U)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the Bristol stool type 1?

A

separate hard lumps, like nuts (hard to pass)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the Bristol stool type 2?

A

sausage shaped, but lumpy

19
Q

What is the Bristol stool type 3?

A

like a sausage, but cracks on the surface

20
Q

What is the Bristol stool type 4?

A

like a sausage or snake, smooth and soft

21
Q

What is the Bristol stool type 5?

A

soft blobs with clear cut edges

22
Q

What is the Bristol stool type 6?

A

fluffy pieces with ragged edges, a mushy stool

23
Q

What is the Bristol stool type 7?

A

watery, no solid piece, entirely liquid

24
Q

How do people with IBS present?

A

with varying symptom profiles, most commonly ‘diarrhoea predominant’, ‘constipation predominant’ or alternating symptom profiles
IBS diagnosis should be a consideration when an older person presents with unexplained abdominal symptoms

25
Alongside signs and symptoms reported by the patient, past medical history and physical examination, what blood tests are used to diagnose IBS?
full blood count (FBC) erythrocyte sedimentation rate (ESR) or plasma viscosity C‑reactive protein (CRP) antibody testing for coeliac disease (endomysial antibodies or tissue transglutaminase)
26
What tests might be requested if there are any concerns or other potential causes?
``` ultrasound rigid/flexible sigmoidoscopy colonoscopy, barium enema thyroid function test faecal ova and parasite test faecal occult blood hydrogen breath test (for lactose intolerance and bacterial overgrowth) ```
27
What are the main non-pharmacological factors involved in the management of IBS?
``` stress and anxiety diet diarrhoea and/or bloating constipation adequate fluid intake probiotic supplement (taken for at least four weeks) exercise ```
28
Why are stress and anxiety related to the management of IBS?
the ability to support patients to identify causes and triggers can reduce the impact of the condition
29
Why is diet related to the management of IBS?
regular meals 30 mg fibre per day (most people do not eat the recommended amount) adjusted to the patient's symptoms
30
Why is diarrhoea and/or bloating related to the management of IBS?
reduce intake of insoluble fibre (e.g. wholemeal or high-fibre flour and bread, cereals high in bran, whole grains) avoid foods that exacerbate symptoms (e.g. caffeine, alcohol, carbonated drinks)
31
Why is constipation related to the management of IBS?
increase soluble fibre supplements (e.g. ispaghula) or foods high in soluble fibre (e.g. oats and linseed) this is slowly titrated to an optimal level that minimises flatulence and bloating (may take several weeks)
32
Why is exercise related to the management of IBS?
stimulate the GI system | advised that patients engage in 30 mins of moderate intensity physical activity at least 5 days per week
33
What is the first-line pharmacological therapy for IBS?
adjusted doses of laxative (lactulose) constipation, or antimotility (loperimide) diarrhoea according to the clinical response the dose should be titrated according to stool consistency, with the aim of achieving a soft, well‑formed stool (Bristol stool type 4)
34
What is the second-line pharmacological therapy for IBS?
``` tricyclic antidepressants (TCAs) if laxatives, loperamide or antispasmodics ineffective e.g. amitriptyline 5-10 mg at night ```
35
OSMOTIC LAXATIVES Lactulose, macrogols, magnesium sulfate - actions
they increase osmotic load | these include magnesium salts, disaccharide (lactulose) and ethylene glycol polymers (macrogols)
36
OSMOTIC LAXATIVES Lactulose, macrogols, magnesium sulfate - MOA
poorly absorbed, these agents raise the osmotic load within the gut lumen this causes ingested water to be retained and water also to be withdrawn from the blood stream the increased fluid volume promotes movement along the gut
37
OSMOTIC LAXATIVES Lactulose, macrogols, magnesium sulfate - abs/distrib/elim
taken orally | not absorbed
38
OSMOTIC LAXATIVES Lactulose, macrogols, magnesium sulfate - clinical use
bowel cleansing prior to surgery or examination (MgSO4) constipation (macrogols and lactulose) the effects of lactulose develop after 2-3 days
39
OSMOTIC LAXATIVES Lactulose, macrogols, magnesium sulfate - adverse effects
abdominal cramps, flatulence | few systemic actions because of low absorption
40
ANTIDIARRHOEAL AGENTS Loperamide (similar: diphenoxylate, codeine) - actions
reduces gut motility and secretions | the slower transit time allows for more fluid absorption and more solid stools
41
ANTIDIARRHOEAL AGENTS Loperamide (similar: diphenoxylate, codeine) - MOA
agonist action at µ-opioid receptors in myenteric plexus of gut inhibits peristalsis effects can be reversed by naloxone loperamide and diphenoxylate, but not codeine, achieve low concentrations in CNS, so have few central effects (including analgesia and addiction)
42
ANTIDIARRHOEAL AGENTS Loperamide (similar: diphenoxylate, codeine) - abs/distrib/elim
oral administration metabolized by hepatic cytochrome P450 system diphenoxylate is hydrolyzed to an active metabolite
43
ANTIDIARRHOEAL AGENTS Loperamide (similar: diphenoxylate, codeine) - clinical use
acute diarrhoea chronic diarrhoea associated with inflammatory bowel disease diphenoxylate is commonly administered in a combined preparation with atropine
44
ANTIDIARRHOEAL AGENTS Loperamide (similar: diphenoxylate, codeine) - adverse effects
drowsiness and nausea constipation and abdominal cramps CNS depression may occur in overdose